| Title | Clinical Information for Patients with Atrial Fibrillation Undergoing Rivaroxaban Based on Gene Polymorphisms |
|---|---|
| Description | To investigate the impact of genetic polymorphisms on the pharmacokinetics (PK) and pharmacodynamics (PD) of rivaroxaban among patients with non-valvular atrial fibrillation (NVAF). A prospective study was conducted with 173 NVAF patients receiving rivaroxaban. Blood samples from each participant were obtained for adjusted trough plasma rivaroxaban concentration (C0h/D), genotype determination and coagulation parameters. All patients clinical information and outcomes were recorded during scheduled follow-ups. |
| Organism | Homo sapiens |
| Data Type | Demographic Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA012489 |
| Release Date | 2024-12-31 |
| Submitter | Li Xiaoye (li.xiaoye@zs-hospital.sh.cn) |
| Organization | Zhongshan Hospital, Fudan University |
| Submission Date | 2022-10-14 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX002057-03 | Baseline demographic data | 173 | Demographic Data | 39.6 KB | xlsx | Controlled |
| OMIX002057-04 | Laboratory test | 173 | Demographic Data | 125.9 KB | xlsx | Controlled |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|